Table 3 EOPC and older PDAC tumour characteristics and treatment details
From: Demographic, clinical, and pathological features of early onset pancreatic cancer patients
| Tumour Characteristics | EOPC (N = 35), % (≤50 years) | PDAC (N = 334), % (> 50 years) | p value |
|---|---|---|---|
| Resectable | 0.015 | ||
| Yes | 8 (22.9%) | 147 (44%) | |
| No | 27 (77.1%) | 186 (56%) | |
| Missing | 0 | 1 (0%) | |
| Location | 0.579 | ||
| Head/Uncinate | 27 (77%) | 265 (79%) | |
| Body/Tail | 8 (23%) | 62 (19%) | |
| Missing | 0 | 7 (2%) | |
| Differentiation grade | 0.315 | ||
| Well | 2 (6%) | 15 (4%) | |
| Moderate | 16 (46%) | 127 (38%) | |
| Poor | 12 (34%) | 170 (51%) | |
| Missing | 5 (14%) | 22 (7%) | |
| Stages | 0.194 | ||
| I | 2 (5.8%) | 16 (5%) | |
| II* | 6 (17.1%) | 117(34%) | |
| III | 19 (54.2%) | 140 (42%) | |
| IV | 8 (22.9%) | 57 (17%) | |
| Missing | 0 | 4 (1%) | |
| Perineural invasion | 0.348 | ||
| Yes | 12 (34%) | 142 (43%) | |
| No | 23 (66%) | 192 (57%) | |
| Perivascular invasion | |||
| Yes | 7 (20%) | 122 (37%) | 0.051 |
| No | 28 (80%) | 212 (63%) | |
| Chemotherapy/ radiotherapy | 0.008 | ||
| Yes | 21 (60%) | 153 (46%) | |
| No | 5 (14%) | 131 (39%) | |
| Missing | 9 (26%) | 50 (15%) | |
